Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
7,44 USD | +3,05 % | -6,06 % | -26,55 % |
13/03 | Transcript : Editas Medicine, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 02:05 PM | |
29/02 | EDITAS MEDICINE, INC. : Barclays se mantiene neutral. | ZM |
Resumen de negocios
Número de empleados: 265
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Genome Editing Technology
100,0
%
| 20 | 100,0 % | 78 | 100,0 % | +296,32 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 20 | 100,0 % | 78 | 100,0 % | +296,32 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 01/06/22 |
Erick Lucera
DFI | Director of Finance/CFO | 57 | 17/05/23 |
Linda Burkly
CTO | Chief Tech/Sci/R&D Officer | - | 24/07/23 |
Mei Baisong
CTO | Chief Tech/Sci/R&D Officer | 60 | 18/07/22 |
Chi Li
LAW | General Counsel | - | 14/06/21 |
Linea Aspesi
HRO | Human Resources Officer | - | 01/02/23 |
Charlene Stern
LAW | General Counsel | - | 01/01/13 |
Kate X. Zhang
PRN | Corporate Officer/Principal | - | 01/10/18 |
Caren Deardorf
PRN | Corporate Officer/Principal | 59 | 26/09/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Emma Reeve
CHM | Chairman | 63 | 03/09/21 |
David Scadden
BRD | Director/Board Member | 71 | 06/02/19 |
Akshay Vaishnaw
BRD | Director/Board Member | 61 | 28/07/16 |
Andrew Hirsch
BRD | Director/Board Member | 53 | 30/05/17 |
Jessica Hopfield
BRD | Director/Board Member | 59 | 16/02/18 |
Elliott Levy
BRD | Director/Board Member | 64 | 11/04/23 |
Director/Board Member | 65 | 26/10/21 | |
Gilmore O’Neill
CEO | Chief Executive Officer | 59 | 01/06/22 |
Meeta Chatterjee
BRD | Director/Board Member | 69 | 17/12/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 81 813 850 | 81 066 427 ( 99,09 %) | 0 | 99,09 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-26,55 % | 593 M | |
+9,16 % | 45,97 mil M | |
+53,46 % | 43,93 mil M | |
+11,20 % | 42,34 mil M | |
-8,59 % | 28,27 mil M | |
+16,40 % | 27,18 mil M | |
-19,34 % | 19,44 mil M | |
+13,95 % | 13,83 mil M | |
+31,56 % | 12,4 mil M | |
+10,63 % | 11,45 mil M |
- Bolsa
- Acciones
- Acción Editas Medicine, Inc. - Nasdaq
- Empresa Editas Medicine, Inc.